Coversyl ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
167マルファン症候群2

167. マルファン症候群


臨床試験数 : 21 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 50
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-000749-13-GB
(EUCTR)
30/07/200520/06/2005 A Randomised Double-Blind Trial of Medical Treatment In Marfan Syndrome. A Randomised Double-Blind Trial of Medical Treatment In Marfan Syndrome. Marfan SyndromeTrade Name: Atenolol
Product Name: Atenolol
Product Code: N/A
INN or Proposed INN: N/A
Other descriptive name: N/A
Trade Name: Coversyl
Product Name: Coversyl
Product Code: N/A
INN or Proposed INN: N/A
Other descriptive name: PERINDOPRIL
Trade Name: Verapamil
Product Name: Verapamil SR
Product Code: N/A
INN or Proposed INN: N/A
Other descriptive name: N/A
Cardiff UniversityNULLNot Recruiting Female: yes
Male: yes
60 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yesUnited Kingdom
2NCT00485368
(ClinicalTrials.gov)
January 200411/6/2007Angiotensin Converting Enzyme Inhibitors in Marfan SyndromeThe Effect of an Angiotensin Converting Enzyme Inhibitor on Aortic Wall Properties in Patients With Marfan Syndrome.Marfan SyndromeDrug: Coversyl (perindopril)Bayside HealthBaker Heart Research Institute;The AlfredCompleted18 Years40 YearsBoth17Phase 3NULL